Insider · CIK 0001841497
Mitchell Arnold
Files at PTPI (Petros Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Mitchell Arnold files SEC Form 4 as officer at PTPI (Petros Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mitchell Arnold has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | PTPI Petros Pharmaceuticals, Inc. | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 150,000 | Feb 21, 2025 |
| Dec 21, 2023 | PTPI Petros Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 26, 2023 |
Questions about Mitchell Arnold
Answered from the filings on this page, as of the latest one.
Is Mitchell Arnold buying or selling?
Mitchell Arnold has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mitchell Arnold's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mitchell Arnold has 0.
Where does Mitchell Arnold file Form 4?
Mitchell Arnold has filed Form 4 at PTPI (Petros Pharmaceuticals, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.